HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FOXN1
forkhead box N1
Chromosome 17 Β· 17q11.2
NCBI Gene: 8456Ensembl: ENSG00000109101.8HGNC: HGNC:12765UniProt: O15353
37PubMed Papers
23Diseases
0Drugs
79Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of epithelial cell differentiationprotein bindingchromatinregulation of transcription by RNA polymerase IIT-cell immunodeficiency, congenital alopecia, and nail dystrophyT-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominantAlymphoid cystic thymic dysgenesisThymic aplasia
✦AI Summary

FOXN1 is a forkhead box transcription factor that serves as a master regulator of thymic epithelial cell (TEC) development and function 1. It directs the differentiation of progenitor TECs into functional cortical and medullary TECs throughout fetal and postnatal thymic development, regulating genes essential for T-cell development including MHC Class II, DLL4, and CCL25 1. FOXN1 is critical for maintaining the three-dimensional thymic microstructure and vascularization necessary for immune tolerance and T-cell selection 2. Beyond the thymus, FOXN1 promotes epithelial differentiation in skin and hair follicles, influencing the developmental transition from scar-free to scar-forming wound healing 3. Loss-of-function FOXN1 mutations cause severe primary immunodeficiency (Nude/SCID syndrome) characterized by thymic aplasia and T-cell lymphopenia, representing the first SCID phenotype resulting from stromal rather than hematopoietic defects 1. During thymic aging, FOXN1 downregulation correlates with emergence of atypical TECs that form non-productive epithelial clusters and impair regenerative capacity 4. Age-related FOXN1 decline is a key component of thymic involution, driving immune senescence 5. FOXN1 mutations are associated with T-cell immunodeficiency, congenital alopecia, and nail dystrophy, highlighting its pleiotropic roles in immune and epithelial tissue development.

Sources cited
1
FOXN1 is a master regulator of TEC development directing differentiation of progenitor cells into functional cortical and medullary TECs; FOXN1 mutations cause Nude/SCID syndrome with alymphoid thymic dysgenesis
PMID: 24432845
2
FOXN1 is critical for thymic structure and function; thymic disorders including developmental defects are primary causes of severe immunodeficiency
PMID: 38228406
3
Age-associated downregulation of FOXN1 correlates with emergence of atypical TECs that impair thymic regeneration and function
PMID: 39112630
4
FOXN1 is a key transcription factor regulating age-associated thymic involution and immune senescence
PMID: 37659170
5
FOXN1 regulates skin development, homeostasis, and wound healing, influencing the transition from fetal scar-free to adult scar-forming healing
PMID: 29973508
6
FOXN1 is a member of the FOX transcription factor family; mutations in FOXN1 are associated with human congenital disorders
PMID: 15492844
Disease Associationsβ“˜23
T-cell immunodeficiency, congenital alopecia, and nail dystrophyOpen Targets
0.82Strong
T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominantOpen Targets
0.76Strong
Alymphoid cystic thymic dysgenesisOpen Targets
0.67Moderate
Thymic aplasiaOpen Targets
0.56Moderate
Nezelof syndromeOpen Targets
0.55Moderate
severe combined immunodeficiencyOpen Targets
0.49Moderate
T-B- severe combined immunodeficiencyOpen Targets
0.46Moderate
T-B+ severe combined immunodeficiencyOpen Targets
0.46Moderate
T+ B+ severe combined immunodeficiencyOpen Targets
0.46Moderate
autismOpen Targets
0.26Weak
genetic disorderOpen Targets
0.19Weak
disorder of pharynxOpen Targets
0.18Weak
lymphatic system diseaseOpen Targets
0.17Weak
stricture or kinking of ureterOpen Targets
0.10Weak
ringed hair diseaseOpen Targets
0.09Suggestive
intracranial hemorrhageOpen Targets
0.09Suggestive
Alopecia-intellectual disability syndromeOpen Targets
0.09Suggestive
Alopecia universalisOpen Targets
0.09Suggestive
hypotrichosis simplexOpen Targets
0.09Suggestive
uncombable hair syndromeOpen Targets
0.08Suggestive
T-cell immunodeficiency with thymic aplasiaUniProt
T-cell immunodeficiency, congenital alopecia, and nail dystrophyUniProt
T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominantUniProt
Pathogenic Variants79
NM_001369369.1(FOXN1):c.723C>G (p.Tyr241Ter)Pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2025β†’ Residue 241
NM_001369369.1(FOXN1):c.1376C>A (p.Ser459Ter)Pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2025β†’ Residue 459
NM_001369369.1(FOXN1):c.246C>A (p.Cys82Ter)Pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 82
NM_001369369.1(FOXN1):c.1579_1580del (p.Gly526_Thr527insTer)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 526
NM_001369369.1(FOXN1):c.1049C>T (p.Pro350Leu)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy|not specified
β˜…β˜…β˜…β˜†2024β†’ Residue 350
NM_001369369.1(FOXN1):c.340C>T (p.Arg114Ter)Pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy|Severe combined immunodeficiency disease
β˜…β˜…β˜…β˜†2024β†’ Residue 114
NM_001369369.1(FOXN1):c.974T>C (p.Leu325Pro)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 325
NM_001369369.1(FOXN1):c.1392_1401del (p.Pro465fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant
β˜…β˜…β˜…β˜†2024β†’ Residue 465
NM_001369369.1(FOXN1):c.1418del (p.Pro473fs)Likely pathogenic
T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 473
NM_001369369.1(FOXN1):c.1364_1367del (p.Tyr455fs)Likely pathogenic
T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|not provided|T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 455
NM_001369369.1(FOXN1):c.1367T>A (p.Leu456Ter)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant
β˜…β˜…β˜…β˜†2024β†’ Residue 456
NM_001369369.1(FOXN1):c.1010del (p.Gly337fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 337
NM_001369369.1(FOXN1):c.962A>G (p.His321Arg)Likely pathogenic
not provided|T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 321
NM_001369369.1(FOXN1):c.907del (p.Glu303fs)Likely pathogenic
not provided|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 303
NM_001369369.1(FOXN1):c.1315del (p.Leu439fs)Likely pathogenic
not provided|T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant
β˜…β˜…β˜…β˜†2024β†’ Residue 439
NM_001369369.1(FOXN1):c.1585del (p.Leu529fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell immunodeficiency, congenital alopecia, and nail dystrophy;T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant
β˜…β˜…β˜…β˜†2024β†’ Residue 529
NM_001369369.1(FOXN1):c.880G>C (p.Val294Leu)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 294
NM_001369369.1(FOXN1):c.1168del (p.Glu390fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 390
NM_001369369.1(FOXN1):c.1296del (p.Ile433fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 433
NM_001369369.1(FOXN1):c.1275_1278del (p.Leu426fs)Likely pathogenic
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
β˜…β˜…β˜…β˜†2024β†’ Residue 426
View on ClinVar β†—
Related Genes
WNT5BProtein interaction81%HOXC13Protein interaction79%AIREProtein interaction76%SUPT6HProtein interaction76%WNT10BProtein interaction72%GCM2Protein interaction72%
Tissue Expression6 tissues
Lung
100%
Bone Marrow
17%
Ovary
17%
Liver
17%
Heart
0%
Brain
0%
Gene Interaction Network
Click a node to explore
FOXN1WNT5BHOXC13AIRESUPT6HWNT10BGCM2
PROTEIN STRUCTURE
Preparing viewer…
PDB6EL8 Β· 1.61 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.44Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.28 [0.18–0.44]
RankingsWhere FOXN1 stands among ~20K protein-coding genes
  • #10,625of 20,598
    Most Researched37
  • #940of 5,498
    Most Pathogenic Variants79 Β· top quartile
  • #2,425of 17,882
    Most Constrained (LOEUF)0.44 Β· top quartile
Genes detectedFOXN1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Human FOX gene family (Review).
PMID: 15492844
Int J Oncol Β· 2004
1.00
2
Primary and secondary defects of the thymus.
PMID: 38228406
Immunol Rev Β· 2024
0.90
3
Thymus aging and immune reconstitution, progresses and challenges.
PMID: 37659170
Semin Immunol Β· 2023
0.80
4
Age-related epithelial defects limit thymic function and regeneration.
PMID: 39112630
Nat Immunol Β· 2024
0.70
5
The Effect of Lymphangiogenesis in Transplant Arteriosclerosis.
PMID: 36515099
Circulation Β· 2023
0.60